Recently, Viva Biotech experts will attend 40th Annual J.P. Morgan Health Care Conference, PharmThink 2022, SIT 2022, China Pharmaceutical Developers Conference, 12th Annual ChemPharma International Summit-Asia, BIT 2022, 2nd China Pharma Due Diligence Conference and BIOLIGN Innovators World. Focusing on various segments of the pharmaceutical industry, what new insights will be generated?
The 40th Annual J.P. Morgan Health Care Conference
The 40th Annual Health Care Conference will take place virtually on January 10-13, 2022 (EST). This premier conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community. Dr. Han Dai, CIO of Viva Biotech and Head of Viva BioInnovator, will attend the conference at 3:30pm EST on January 11 (4:30am CST on January 12) and deliver a keynote speech on Viva Biotech's world-leading one-stop drug R&D and production services and future strategies.
January 11-12, 2022, PharmThink will be held in Shanghai. Pharmaceutical professionals are gathering to discuss challenges in the development of small molecule innovative drugs, improved new drugs, and formulation development. The conference will focus on recent technical and market trends in R&D, target discovery, clinical, prescribing, process and quality control. Dr. Jianhua Cai, Senior Vice President of Viva Biotech, will share his insights on "Affinity Based Screening" during the event. Welcome to visit us to know more about Viva Biotech at booth A08.
March 3-4, 2022, SIT 2022 will be held in Suzhou. The Forum focuses on the latest trends of cutting-edged innovative drug R&D cases, undruggable targets, anticancer drugs, AI-driven drug discovery, etc. Dr. Han Dai, CIO of Viva Biotech and Head of Viva BioInnovator, will join the event as one of the panelists of " New Technologies and Thinking for Small Molecule Drug Discovery".
China Pharmaceutical Developers Conference(中国医药开发者大会)
March 17-18, 2022, China Pharmaceutical Developers Conference(中国医药开发者大会) will be held in Hangzhou. The conference focuses on several popular topics including industry trends, popular targets, development structure, CMC studies, clinical studies, quality control, commercialization, etc. Dr. Jianguo Ma, Senior Vice President of Viva Biotech, will deliver a keynote speech on " Screening of Salt Form and Crystalline Form During Drug Development".
CIS-Asia2022｜12th Annual ChemPharma International Summit-Asia
March 29-April 1, 2022, the 12th Annual ChemPharma International Summit-Asia, jointly organized by Best Media and Chinese Pharmaceutical Association, will be held in Beijing. Dr. Mingda Bi, Vice President of Langhua Pharmaceutical, will deliver a keynote speech on " IVIVC Development of OM Sustained-Release Tablet ".
March 30-31, 2022, BIT will take place in Shanghai. Dr. Han Dai, CIO of Viva Biotech and Head of Viva BioInnovator, will join the Session 5 as one of the panelists and discuss the topic of “Innovative drug development progress of local pharmaceutical companies”.
The 2nd China Pharma Due Diligence Conference
March 30 -April 1, 2022, the 2nd China Pharmaceutical Due Diligence Conference will be held in the Longemont Shanghai Hotel (Changning District). The conference attendees include domestic and international pharmaceutical and biotech companies, venture capital institutions, law firms, accounting firms, consulting firms, etc. The topics focuses on due diligence items including pharmaceutical licensing, business development, M&A, IPO, etc. Dr. Han Dai, CIO of Viva Biotech and Head of Viva BioInnovator, will join the event as one of the panelists of “How to achieve joint development between investment institutions and startups”.
BIOLIGN Innovators World
April 26-27, 2022, BIOLIGN Innovators World will be held in Nanjing. Dr. Han Dai, CIO of Viva Biotech and Head of Viva BioInnovator, is invited to the conference to deliver a speech.